SAN DIEGO, Nov. 6, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Medical Marijuana, Inc. CEO Dr. Stuart Titus has been invited to speak at the CBD Symposium on November 6, 2018, hosted by SUCCESS Partners® and Direct Selling News.
The CBD Symposium, held at the SUCCESS Partners Headquarters, will focus on the many cannabis and cannabidiol (CBD) market opportunities as well as the medical research behind cannabis’ many therapeutic uses. The event will address the current opportunities and challenges of market entry and industry experts will share their insights on the many different aspects of CBD in the direct selling market, including the legal landscape, regulatory provisions, product development and manufacturing. The symposium will take place Nov. 6 from 9 a.m. to 3 p.m. CDT in Plano, TX.
“I look forward to speaking with other industry leaders regarding the benefits and challenges of entering the CBD market,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “The event is a great opportunity for the company to join others on the forefront of this fast-growing sector as we discuss our endeavors to help the industry grow and flourish.”
SUCCESS Partners® empowers companies to achieve their full potential by providing strategic and creative solutions for growth, focusing on creating results through partnership, expertise, and innovation. Direct Selling News is an online and print publication that direct selling executives turn to for information and resources to improve their companies. Designed to help busy decision-makers stay informed, this publication provides up-to-the-minute industry headlines from staff writers and up to date stock updates.
“With the U.S. hemp market poised to reach a $1 billion dollars in 2018, led by hemp-derived CBD, we are thrilled with the potential for further growth,” continued Titus.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer